SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-311936"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-311936" > Maintenance versus ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004951naa a2200973 4500
001oai:DiVA.org:uu-311936
003SwePub
008170103s2017 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:135082530
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3119362 URI
024a https://doi.org/10.1016/j.bbmt.2016.11.0112 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1350825302 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Cornell, Robert F4 aut
2451 0a Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
264 1b Elsevier BV,c 2017
338 a print2 rdacarrier
520 a Bortezomib (V), lenalidomide (R), cyclophosphamide (C), and dexamethasone (D) are components of the most commonly used modern doublet (RD, VD) or triplet (VRD, CVD) initial induction regimens before autologous hematopoietic cell transplantation (AHCT) for multiple myeloma (MM) in the United States. In this study we evaluated 693 patients receiving "upfront" AHCT after initial induction therapy with modern doublet or triplet regimens using data reported to the Center for International Blood and Marrow Transplant Research from 2008 to 2013. Analysis was limited to those receiving a single AHCT after 1 line of induction therapy within 12 months from treatment initiation for MM. In multivariate analysis, progression-free survival (PFS) and overall survival were similar irrespective of induction regimen. However, high-risk cytogenetics and nonreceipt of post-transplant maintenance/consolidation therapy were associated with higher risk of relapse. Patients receiving post-transplant therapy had significantly improved 3-year PFS versus no post-transplant therapy (55% versus 39%, P = .0001). This benefit was most evident in patients not achieving at least a complete response post-AHCT (P = .005). In patients receiving upfront AHCT, the choice of induction regimen (doublet or triplet therapies) appears to be of lower impact than use of post-transplant therapy.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng
653 a Myeloma
653 a Transplantation
653 a Survival
653 a Relapse
653 a Chemotherapy
653 a Maintenance
700a D'Souza, Anita4 aut
700a Kassim, Adetola A4 aut
700a Costa, Luciano J4 aut
700a Innis-Shelton, Racquel D4 aut
700a Zhang, Mei-Jie4 aut
700a Huang, Jiaxing4 aut
700a Abidi, Muneer4 aut
700a Aiello, Jack4 aut
700a Akpek, Gorgun4 aut
700a Bashey, Asad4 aut
700a Bashir, Qaiser4 aut
700a Cerny, Jan4 aut
700a Comenzo, Raymond4 aut
700a Diaz, Miguel Angel4 aut
700a Freytes, César4 aut
700a Gale, Robert Peter4 aut
700a Ganguly, Siddhartha4 aut
700a Hamadani, Mehdi4 aut
700a Hashmi, Shahrukh4 aut
700a Holmberg, Leona4 aut
700a Hossain, Nasheed4 aut
700a Kamble, Rammurti T4 aut
700a Kharfan-Dabaja, Mohamed4 aut
700a Kindwall-Keller, Tamila4 aut
700a Kyle, Robert4 aut
700a Kumar, Shaji4 aut
700a Lazarus, Hillard4 aut
700a Lee, Cindy4 aut
700a Maiolino, Angelo4 aut
700a Marks, David I4 aut
700a Meehan, Kenneth4 aut
700a Mikhael, Joe4 aut
700a Nath, Rajneesh4 aut
700a Nishihori, Taiga4 aut
700a Olsson, Richard F.u Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD)4 aut0 (Swepub:uu)riols677
700a Ramanathan, Muthalagu4 aut
700a Saad, Ayman4 aut
700a Seo, Sachiko4 aut
700a Usmani, Saad4 aut
700a Vesole, David4 aut
700a Vij, Ravi4 aut
700a Vogl, Dan4 aut
700a Wirk, Baldeep M4 aut
700a Yared, Jean4 aut
700a Krishnan, Amrita4 aut
700a Mark, Tomer4 aut
700a Nieto, Yago4 aut
700a Hari, Parameswaran4 aut
710a Uppsala universitetb Centrum för klinisk forskning i Sörmland (CKFD)4 org
773t Biology of blood and marrow transplantationd : Elsevier BVg 23:2, s. 269-277q 23:2<269-277x 1083-8791x 1523-6536
856u http://www.bbmt.org/article/S108387911630489X/pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-311936
8564 8u https://doi.org/10.1016/j.bbmt.2016.11.011
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:135082530

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy